full
image
#666666
http://www.infarco.com/wp-content/themes/zap-installable/
http://www.infarco.com/en//
#03b4b3
style1

3P Biopharmaceuticals : biotechnology at the international level

3P Biopharmaceuticals,
biotechnology at the international level

3P Biopharmaceuticals specialises in developing biotechnological products and processes: advanced therapy medicinal products,  vaccines, and biosimilar medicines, such as proteins and monoclonal antibodies for several therapeutic indications.

Infarco is the majority owner of the equity of the company. Since its inception in 2006, 3P, as production partner, accompanies its clients in the development of biological pharmaceuticals, from the initial research and preclinical and clinical trials, through to its marketing.
www.3pbio.com

 

default
Loading posts...
link_magnifier
#363636
off
loading
off